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Abstract 
Background: Injecting drug users (IDUs) and prisoners are considered to be highly vulnerable to 
human immunodeficiency virus (HIV) infection in Iran. This study was carried out to determine the 
prevalence of HIV infection among IDUs released from jail in Bahar (Hamadan, Iran). 
Methods: In a cross-sectional study, 118 IDUs who were prisoners during 2001-07 were evaluated. 
Their demographic and personal characteristics were assessed by a questionnaire. In order to 
determine HIV-positive individuals, blood samples were obtained from the participants and tested by 
enzyme-linked immunosorbent assay and Western blot technique. 
Findings: Overall, 20.3% of the subjects had used non-sterile injecting equipment during their 
imprisonment. The prevalence of HIV infection among the studied population was 4.2%. 
Conclusion: As the prevalence of HIV among IDUs released from jail is high, it is necessary for prison 
authorities to take measures against the increase in the prevalence of HIV among this group. 
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Introduction  
Acquired immunodeficiency syndrome (AIDS) 
is the world's fourth leading cause of death. Of 
approximately 14000 new cases of human 
immunodeficiency virus (HIV) infection that 
occur daily around the world, 95% occur in 
developing countries.1 It is estimated that  
70-100 thousand unidentified people are living 
with HIV in Iran.2 
Injecting drug use and sexual transmission 
are recognized as the primary causes of HIV 
infection. In recent years, the number of 
injection drug users (IDUs) living with HIV has 
been increasing rapidly around the world, 
including the Middle East and Iran. Iranian 
IDUs are more vulnerable to HIV infection than 
other members of the community. After an HIV 
epidemic among IDUs in certain jails in Iran in 
1996, identified cases increased drastically until 
2004. Then, the numbers decreased temporarily 
for a while and remained stable up to the 
present date.3 
In spite of the considerable programs to 
reduce harm in jails, a study in 2009 revealed 
that more than 45.0% of men and 15% of women 
in all jails in Iran had used drugs during the 
month before the study. It also found injecting 
drug use in 1.2% of men.4 Most prisoners spend 
only a short time in jail. They take leave or are 
released from jail back into the society. They will 
then have relationships within the society. 
Hence, a drug user released from the jail not only 
is at risk of AIDS and hepatitis, but can also play a 
role as a source of this infection in the society.5 
Different studies in Iran have shown that 
history of imprisonment and injecting drug use 
in jail are among the primary causes of HIV 
infection. Therefore, we carried out this study 
to determine the prevalence of HIV infection 
among IDUs in Bahar (a city in Iran), who were 
prisoners between 2001 and 2007. 
 
Methods 
As the statistical population of this cross-
sectional study was restricted, we used the 
complete census. We also extracted the names of 
all IDUs who were Bahar city inhabitants and 
had a history of imprisonment in the central jail 
of Hamadan, Iran, between 2001 and 2006. The 
names of a total number of 125 people were 
obtained from their files in Alvand Prison, 
Hamadan, Iran. Each person was given a specific 
code to enable their information, blood samples 
and test results to be recognized by their codes. 
We visited all subjects at their residence or 
workplace and explained the aims of the study. 
They were requested to participate. After 
obtaining their informed consent, they were 
asked to complete a questionnaire including 
demographics and other personal traits. 
Subsequently, a 5 ml blood sample was taken 
from each person. With appropriate 
precautions, the blood samples were carried in 
iced containers to the nearest local laboratory 
for centrifugation and serum separation. In the 
local laboratory, serum samples were 
transmitted into microtubes, encoded, and sent 
to the state central blood transfusion laboratory. 
At the central blood transfusion laboratory, 
samples were analyzed by enzyme-linked 
immunosorbent assay (ELISA) and standard 
kits. Samples with positive ELISA test were 
further analyzed by Western blot technique. If 
the results were again positive, the subjects 
were confirmed to be HIV positive. 
The results were analyzed by descriptive 
statistics. The associations of categorical 
variables were tested by chi-square tests in SPSS 
for Windows 16.0 (SPSS Inc., Chicago, IL, USA). 
 
Results 
From 125 people who were contacted,  
118 individuals were available and interested in 
taking part. The mean age of subjects was  
32.04 ± 8.05 years. Age, marital status, residence 
(urban or rural), literacy, and occupation were 
not considered as HIV risk factors (P > 0.05) 
(Table 1). The mean age of subjects at the time 
of first narcotic drug use was 18.2 ± 5.09 years. 
While 33.9% of the subjects had their first 
experience of drugs at an age younger than 15, 
the first experience of 40.7% of the participants 
had occurred between ages 16 and 20.  
Most subjects (86.5%) had secondary school 
education. A total of 50.8% were unemployed 
or did not have a permanent job (Table 1).  
Non-sterile injecting equipment was used by  
24 subjects (20.3%) inside prison and by 41 
(34.7%) after being released. On the other hand, 
24 participants (20.3%) had quit their drug 
using habit after their release. Age, marital 
status, place of residence (urban or rural), 
literacy, and occupation were not considered as 
HIV risk factors (P > 0.05). Finally, among  
118 IDUs whose blood samples were tested for 
HIV, 5 subjects (4.23%) were HIV-positive. 
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Table 1. Demographic characteristics of injection drug users who were in prison in 
Bahar (a city in Iran) during 2001-07  
 Frequency Percent HIV-positive* P 
Age Group (year)     
Younger than 25 34 28.8 0 (0.0) 
0.08 
26-30 26 22.0 1 (3.8) 
31-35 20 16.9 3 (15.0) 
36-40 18 15.4 1 (5.6) 
Older than 41 20 16.9 0 (0.0) 
Marital Status     
Single 66 55.9 3 (4.5) 0.85 Married 52 44.1 2 (3.8) 
Residence     
Urban 64 59.8 4 (6.2) 0.34 Rural 43 40.2 1 (2.3) 
Education     
Illiterate 9 7.6 0 (0.0) 
0.57 
Primary school 51 43.3 3 (5.9) 
Secondary school 42 35.6 1 (2.4) 
High School 7 5.9 0 (0.0) 
Diploma 6 5.1 1 (16.7) 
College degree 3 2.5 0 (0.0) 
Job     
Farmer 6 5.1 0 (0.0) 
0.28 
Worker 19 16.1 0 (0.0) 
Self-employed 17 14.4 0 (0.0) 
Other employment 16 13.6 0 (0.0) 
Unemployed 60 50.8 5 (8.3) 
HIV: Human immunodeficiency virus; *Values are expressed as number (percentage in group) 
 
Discussion 
Our study showed 4.3% of IDUs in an Iranian 
city to be HIV-positive. Other studies in other 
cities of Iran reported similar results. In a study 
on 5530 prisoners from 27 jails in Iran, 5.2% of 
subjects with an injecting background were 
HIV-positive.6 In another study on prisoners in 
three central provinces in Iran, 6.6% were  
HIV-positive.5 Other studies carried out in 
other countries have shown various results. For 
instance, 7.5% of prisoners in Italy have been 
reported as HIV-positive.7 
In this study, the mean age of subjects at the 
time of first narcotic drug use was 18.2 ± 5.09 
years. A separate study on IDUs in Shiraz 
showed that the mean age of first time narcotic 
drugs use was 18.63 ± 1.60 years. Therefore, the 
majority of IDUs have their first experience as 
teenagers or young adults.8 Preventive 
measures should thus be taken, especially 
among secondary school students.  
Most of our participants had secondary 
school education and were unemployed. 
Hence, low education level, unemployment, 
and undesirable financial status are crucial 
factors in encouraging individuals to use drugs 
and to indulge in dangerous actions such as 
using non-sterile injecting equipment. 
Previous studies have shown that 
HIV/AIDS is increasing among IDUs in Iran. In 
fact the triangle of AIDS, addiction, and jail are 
considered as major health problems in Iran. 
Zamani et al. suggested an average of 14.3% 
Iranian IDUs to be HIV-positive. According to 
their findings, the rates varied between 0.0% 
and 35.7% in different provinces.3 
We found that 55.0% of the prisoners had 
used non-sterile injecting equipment either as 
prisoners or after being released. The use of 
non-sterile injecting equipment demonstrates 
that the IDUs are unaware of the necessity of 
protected injection. Therefore, educational 
programs on the use of sterile injecting 
equipment are required to increase the 
awareness of IDUs and to help reduce the 
potential harm. A study on 1082 IDUs showed 
that 75.0% of the participants had changed their 
risky behaviors after having access to free, 
sterile injecting equipment at drugstores.9 
Therefore, voluntary counseling and testing 
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(VCT) centers, drop-in centers (DIC), and 
drugstores are required to inform and instruct 
the public about HIV/AIDS and to provide 
them with sterile injecting equipment. 
A systematic review showed that the number 
of IDUs in jails of Switzerland, Germany, and 
Spain decreased markedly when they were 
given instructions to avoid using non-sterile 
injecting equipment and were provided with 
sterile equipment.10 Since the only way to protect 
people from AIDS is by prevention, public 
awareness needs to be promoted to reduce the 
incidence of risky behaviors. Therefore, it is 
necessary to test IDUs as they enter jails in order 
to prevent the spread of infection among 
prisoners. In addition, prisoners need to be 
retested as they are released. They should also be 
controlled after release to further prevent their 
risky behaviors. On the other hand, health 
officials and prison authorities have to take 
measures against bringing drugs into jails, using 
non-sterile injecting equipment, and prisoners 
who use drugs in groups. Finally, the number of 
VCT and DIC centers has to be enhanced and 
IDUs should be provided with methadone and 
sterile equipment. 
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  ﭼﻜﻴﺪه
 ﭘﮋوﻫﺶ اﻳﻦ. ﺷﻮﻧﺪ ﻣﻲ ﻣﺤﺴﻮب اناﻳﺮ در VIH ﺑﻪ اﺑﺘﻼ ﻣﺴﺘﻌﺪ و ﭘﺮﺧﻄﺮ ﻫﺎي ﮔﺮوه از زﻧﺪاﻧﻴﺎن و ﻣﻮاد ﺗﺰرﻳﻘﻲ ﻛﻨﻨﺪﮔﺎن ﻣﺼﺮف: ﻣﻘﺪﻣﻪ
  .ﮔﺮﻓﺖ اﻧﺠﺎم ﻫﻤﺪان اﺳﺘﺎن در واﻗﻊ ﺑﻬﺎر ﺷﻬﺮﺳﺘﺎن در زﻧﺪان ﺳﺎﺑﻘﻪ داراي ﺗﺰرﻳﻘﻲ ﻣﻌﺘﺎدان در VIH ﺑﻪ آﻟﻮدﮔﻲ ﺷﻴﻮع ﺗﻌﻴﻴﻦ ﻫﺪف، ﺑﺎ
  .ﺘﻨﺪداﺷ را 0831- 68 ﻫﺎي ﺳﺎل در زﻧﺪان ﺳﺎﺑﻘﻪ ﻛﻪ ﺑﻮدﻧﺪ ﺑﻬﺎر ﺷﻬﺮﺳﺘﺎن ﺗﺰرﻳﻘﻲ ﻣﻌﺘﺎدان از ﻧﻔﺮ 811 ﭘﮋوﻫﺶ آﻣﺎري ﺟﺎﻣﻌﻪ :ﻫﺎ روش
 اﺳﺘﻔﺎده ﻣﻮاد ﻣﺼﺮف ﺟﻬﺖ ﻣﺸﺘﺮك و اﺳﺘﺮﻳﻞ ﻏﻴﺮ ﺗﺰرﻳﻖ وﺳﺎﻳﻞ از زﻧﺪان داﺧﻞ در ﻣﻄﺎﻟﻌﻪ ﻣﻮرد اﻓﺮاد از درﺻﺪ 02/3 :ﻫﺎ ﻳﺎﻓﺘﻪ
  .ﺑﻮد درﺻﺪ 4/2 ﻣﻄﺎﻟﻌﻪ ﻣﻮرد اﻓﺮاد در VIH ﺑﻪ آﻟﻮدﮔﻲ ﺷﻴﻮع. ﺑﻮدﻧﺪ ﻛﺮده
 ﻛﻪ اﺳﺖ ﺿﺮوري ﺑﺎﺷﺪ، ﻣﻲ ﺑﺎﻻ ﻧﺴﺒﺖ ﺑﻪ زﻧﺪان ﺳﺎﺑﻘﻪ داراي ﺗﺰرﻳﻘﻲ ﻣﻌﺘﺎدان در VIH ﺑﻪ آﻟﻮدﮔﻲ ﻛﻪ ﺟﺎ آن از :ﮔﻴﺮي ﻧﺘﻴﺠﻪ
  .ﮔﻴﺮﻧﺪ ﻛﺎر ﺑﻪ ﺷﻴﻮع اﻳﻦ ﻛﺎﻫﺶ ﺑﺮاي را ﻻزم ﺗﺪاﺑﻴﺮ و راﻫﻜﺎرﻫﺎ زﻧﺪان، ﻣﺴﺆوﻟﻴﻦ
  (اﻳﺮان) ﺑﻬﺎر ﺷﻬﺮﺳﺘﺎن ،VIH اﻳﺪز، ﺗﺰرﻳﻘﻲ، ﻣﻌﺘﺎدان :واژﮔﺎن ﻛﻠﻴﺪي
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